Doctronic, a startup co-founded by Matt Pavelle and Adam Oskowitz, aims to revolutionize the way people access medical advice by leveraging artificial intelligence (AI). The company launched its services in New York on September 2023. Users can input their basic personal information and symptoms into Doctronic's platform, and the AI will provide four possible explanations along with corresponding action suggestions. These include standardized medical history drafts that can be used during consultations. Since December 2023, users have also been able to book 24/7 video consultations with licensed medical professionals through the platform, with typical wait times not exceeding 30 minutes and consultations starting at $39. What sets Doctronic apart is its multi-agent framework. Instead of being a simple AI chatbot, it employs different AI "specialists" to handle various medical issues. These AI systems engage in discussions to reach a consensus, which is then validated by human clinical doctors. Pavelle explains that the platform does not rely on a single large language model (LLM) but selects from a range of models, including those from OpenAI and Anthropic, based on the type of problem presented. This approach ensures more accurate and reliable medical advice. In September 2023, Doctronic secured $5 million in seed funding, led by Union Square Ventures, with additional investments from Tusk Ventures and the startup accelerator HF0. Pavelle's motivation for founding Doctronic stems from his own experiences and those of his friends and family, who struggled to obtain timely and effective medical advice. He believes that if individuals with the best health insurance face such challenges, others with less coverage are likely to face even greater difficulties. To attract users, Doctronic primarily utilizes search engines and specialized landing pages, such as those focused on women's health and information about the COVID-19 pandemic. Pavelle reports that about 50,000 people use Doctronic's services each week, with a significant portion of users returning regularly, indicating strong user satisfaction and product appeal. Moving forward, Doctronic may explore partnerships with gig economy platforms or employers to expand its user base. However, the company currently prioritizes a consumer-centric approach, as the majority of demand comes from individual users. Industry experts see significant potential in Doctronic's use of AI to enhance healthcare accessibility and efficiency. In the AI healthcare market, Doctronic faces competition from other emerging medtech companies like Roon, as well as tech giants such as OpenAI. Roon raised $15 million in November 2024 from Sequoia Capital to develop a video database covering a wide range of health conditions. Despite the competitive landscape, Doctronic has attracted both investors and users with its unique multi-agent framework and user-focused model. A key strength of Doctronic is its highly personalized and integrated product. Pavelle's extensive entrepreneurial experience, having founded 12 companies in various sectors like rental rewards, alcohol shopping, and luxury fashion, brings a diverse set of skills to the table. For Pavelle, the vision for Doctronic extends beyond just providing medical advice; he aims to streamline the healthcare process and improve the overall user experience, making it more accessible and efficient for everyone. The company's innovative approach and strong team background have resonated with users and investors alike, positioning Doctronic as a promising player in the AI healthcare sector. As AI continues to evolve, Doctronic is well-equipped to offer a reliable and user-friendly solution that could transform how people interact with and receive medical advice.